n-acetyltyramine has been researched along with aee 788 in 2 studies
Studies (n-acetyltyramine) | Trials (n-acetyltyramine) | Recent Studies (post-2010) (n-acetyltyramine) | Studies (aee 788) | Trials (aee 788) | Recent Studies (post-2010) (aee 788) |
---|---|---|---|---|---|
25 | 0 | 10 | 83 | 3 | 34 |
Protein | Taxonomy | n-acetyltyramine (IC50) | aee 788 (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.002 | |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.004 | |
Tyrosine-protein kinase Yes | Homo sapiens (human) | 0.0153 | |
Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.74 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.059 | |
Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | 0.002 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.077 | |
Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.002 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y | 1 |
2 other study(ies) available for n-acetyltyramine and aee 788
Article | Year |
---|---|
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites | 2011 |